应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
UMRX Unum Therapeutics
已收盘 10-05 16:00:00 EDT
2.35
+0.00
0.00%
最高
2.35
最低
2.35
成交量
0.00
今开
2.35
昨收
2.35
日振幅
0.00%
总市值
9,980万
流通市值
3,519万
总股本
4,247万
成交额
0.00
换手率
0.00%
流通股本
1,497万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称：
Unum Therapeutics
所属市场：
NASDAQ
上市日期：
--
主营业务：
Unum Therapeutics Inc.于2014年3月根据特拉华州的法律注册成立,是一家临床阶段的生物制药公司，专注于开发和商业化旨在利用患者免疫系统治疗癌症的新型免疫治疗产品。该公司的专有技术，称为抗体偶联T细胞受体（ACTR），是一种通用的工程细胞疗法，旨在与各种肿瘤特异性抗体结合使用，以针对不同的肿瘤类型。他们的产品候选物由ACTRT细胞与临床前或临床开发中经批准和可商购的抗体或抗体共同施用组成。
发行价格：
--
{"stockData":{"symbol":"UMRX","market":"US","secType":"STK","nameCN":"Unum Therapeutics","latestPrice":2.35,"timestamp":1601928000000,"preClose":2.35,"halted":8,"volume":0,"delay":0,"floatShares":14972583,"shares":42469409,"eps":-0.860372,"marketStatus":"已收盘","marketStatusCode":5,"change":0,"latestTime":"10-05 16:00:00 EDT","open":2.35,"high":2.35,"low":2.35,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.860372,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"symbolChange":{"newSymbol":"COGT","executeDate":"2020-10-06"},"adr":0,"listingDate":1522296000000,"adjPreClose":2.35,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/UMRX","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.unumrx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0266},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.2378},{"period":"ytd","weight":0.0625}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Unum Therapeutics Inc.于2014年3月根据特拉华州的法律注册成立,是一家临床阶段的生物制药公司，专注于开发和商业化旨在利用患者免疫系统治疗癌症的新型免疫治疗产品。该公司的专有技术，称为抗体偶联T细胞受体（ACTR），是一种通用的工程细胞疗法，旨在与各种肿瘤特异性抗体结合使用，以针对不同的肿瘤类型。他们的产品候选物由ACTRT细胞与临床前或临床开发中经批准和可商购的抗体或抗体共同施用组成。","exchange":"NASDAQ","name":"Unum Therapeutics","nameEN":"Unum Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unum Therapeutics(UMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Unum Therapeutics(UMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Unum Therapeutics,UMRX,Unum Therapeutics股票,Unum Therapeutics股票老虎,Unum Therapeutics股票老虎国际,Unum Therapeutics行情,Unum Therapeutics股票行情,Unum Therapeutics股价,Unum Therapeutics股市,Unum Therapeutics股票价格,Unum Therapeutics股票交易,Unum Therapeutics股票购买,Unum Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unum Therapeutics(UMRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Unum Therapeutics(UMRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}